Discover 1,825 paid clinical trials in Greensboro, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,825
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Location: Durham NC, Atlanta GA, Columbus OH, Philadelphia PA,
Sponsor: Syndax Pharmaceuticals
Sex: All
Age: 0+
Code: NCT04065399
Phase 1, Phase 2, Recruiting
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
for
Metastatic Castration-Resistant Prostate Cancer
Location: Durham NC, Charlottesville VA, Myrtle Beach SC,
Sponsor: Kyntra Bio
Sex: Male
Age: 18+
Code: NCT06842498
Phase 2, Recruiting
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
for
Bladder Cancer, Squamous Cell Carcinoma of the Lung,
Location: Durham NC, Fairfax VA, Atlanta GA, Philadelphia PA,
Sponsor: EvolveImmune United, Inc
Sex: All
Age: 18+
Code: NCT07217171
Phase 1, Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
for
Pancreatic Cancer, PDAC,
Location: Durham NC, Fairfax VA, Baltimore MD, Atlanta GA,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT07252232
Phase 3, Recruiting
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Study of Choline Chloride for Injection in Adolescent and Adult Patients With Intestinal Failure Receiving Long Term Parenteral Support
for
Choline Deficiency, Liver Injury
Location: Durham NC, Cleveland OH, Chicago IL, Miami Lakes FL,
Sponsor: Protara Therapeutics
Sex: All
Age: 12+
Code: NCT06910943
Phase 2, Phase 3, Recruiting
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
for
Multiple Myeloma (MM)
Location: Durham NC, Baltimore MD, Atlanta GA, Louisville KY,
Sponsor: C4 Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07280013
Phase 1, Recruiting
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: Durham NC, New York NY, Sarasota FL, Boston MA,
Sponsor: Bristol-Myers Squibb
Sex: Male
Age: 18+
Code: NCT06067841
Phase 1, Recruiting
A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer
for
Relapsed/Refractory Small Cell Lung Cancer
Location: Durham NC, Cleveland OH, Nashville TN, Detroit MI,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07325136
Phase 1, Phase 2, Recruiting
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
for
Ovarian Neoplasms, Ovarian Cancer
Location: Durham NC, Norfolk VA, Knoxville TN, Fairfax VA,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT07318558
Phase 3, Recruiting
Family Building Decision Support for Female Adolescent and Young Adult Cancer Survivors
for
Cancer Survivorship, Family Planning,
Location: Durham NC
Sponsor: Duke University
Sex: Female
Age: 18 - 39
Code: NCT07471685
Recruiting
Trans-Rectal Ultrasound of the Female Pelvis for Real-Time MRI-US Fusion Based Needle Tracking
for
Uterine Cancer
Location: Durham NC
Sponsor: Duke University
Sex: Female
Age: 18 - 70+
Code: NCT05977621
Recruiting
A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.
for
Colorectal Cancer
Location: Durham NC, Pittsburgh PA, Florida City FL,
Sponsor: Kahr Bio Australia Pty Ltd
Sex: All
Age: 18+
Code: NCT07235293
Phase 2, Recruiting
A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)
for
Sarcoma,Soft Tissue
Location: Durham NC, Columbus OH, Philadelphia PA,
Sponsor: Intensity Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06263231
Phase 3, Recruiting
Prospective Registry of ADC as First- and Second-line Treatment for Breast Cancer
for
HER2-negative Breast Cancer, HER2 Negative Breast Carcinoma,
Location: Durham NC, The Bronx NY, San Francisco CA
Sponsor: University of California, San Francisco
Sex: All
Age: 18+
Code: NCT06774027
Recruiting
Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors
for
Hematopoietic Stem Cell Transplant
Location: Durham NC, Tampa FL, Boston MA
Sponsor: Brigham and Women's Hospital
Sex: All
Age: 18+
Code: NCT06328127
Recruiting
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
for
NSCLC (Advanced Non-small Cell Lung Cancer)
Location: Durham NC, Fairfax VA, Washington D.C. DC,